Breast Cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis

Oncologist

Volumn 19, Issue 8, 2014, Pages 797-804

  Woodson, Ashley H ^a   Muse, Kimberly I ^a   Lin, Heather ^a   Jackson, Michelle ^a   Mattair, Danielle N ^a   Schover, Leslie ^a   Woodard, Terri ^a   Mc, LaurieKenzie ^a   Theriault, Richard L ^a   Hortobágyi, Gabriel N ^a   Arun, Banu ^a   Peterson, Susan K ^a   Profato, Jessica ^a   Litton, Jennifer K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

BRCA; Breast cancer; Fertility; Genetics; Preimplantation genetic diagnosis

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN, HUMAN;

ADULT; ARTICLE; BRCA GENE; BREAST CANCER; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; IMPACT OF EVENTS SCALE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PATIENT ATTITUDE; PREGNANCY; PREMENOPAUSE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; BREAST NEOPLASMS; FEMALE INFERTILITY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INFERTILITY, FEMALE; MIDDLE AGED; MUTATION; PREGNANCY; PREIMPLANTATION DIAGNOSIS; SURVEYS AND QUESTIONNAIRES;

EID: 84905446510     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2014-0057     Document Type: Article

References (43)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Bath LE, Wallace WH, Shaw MP et al. Depletion of ovarian reserve in young women after treatment for cancer in childhood: Detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003; 18: 2368-2374.
3. Byrne J, Fears TR, Gail MH et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992; 166: 788-793.
4. Goodwin PJ, Ennis M, Pritchard KI et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999; 17: 2365-2370.
5. Balasch J, Gratacós E. Delayed childbearing: Effects on fertility and the outcome of pregnancy. Curr Opin Obstet Gynecol 2012; 24: 187-193.
6. Lee SJ, Schover LR, Partridge AH et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24: 2917-2931.
7. Thewes B, Meiser B, Rickard J et al. The fertilityand menopause-related information needs of younger women with a diagnosis of breast cancer: A qualitative study. Psychooncology 2003; 12: 500-511.
8. Partridge AH, Gelber S, Peppercorn J et al. Webbased survey of fertility issues in young women with breast cancer. J Clin Oncol 2004; 22: 4174-4183.
9. Schover LR, Rybicki LA, Martin BA et al. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer 1999; 86: 697-709.
10. Duffy CM, Allen SM, Clark MA. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 2005; 23: 766-773.
11. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
12. Smith KR, Ellington L, Chan AY et al. Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiol Biomarkers Prev 2004; 13: 733-740.
13. Canada AL, Schover LR. The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology 2012; 21: 134-143.
14. Camp-Sorrell D. Cancer and its treatment effect on young breast cancer survivors. Semin Oncol Nurs 2009; 25: 251-258.
15. Speice J, McDaniel SH, Rowley PT et al. Family issues in a psychoeducation group for women with a BRCA mutation. Clin Genet 2002; 62: 121-127.
16. Lynch HT, Snyder C, Lynch JF et al. Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genet Cytogenet 2006; 165: 91-97.
17. Milunsky A, Milunsky JM. Genetic disorders and thefetus: Diagnosis, prevention, and treatment. 6th edHoboken, NJ: Wiley-Blackwell, 2010.
18. Fasouliotis SJ, Schenker JG. Preimplantation genetic diagnosis principles and ethics. Hum Reprod 1998; 13: 2238-2245.
19. Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: A guideline. Fertil Steril 2013; 99: 37-43.
20. El-Toukhy T, Kamal A, Wharf E et al. Reduction of the multiple pregnancy rate in a preimplantation genetic diagnosis programme after introduction of single blastocyst transfer and cryopreservation of blastocysts biopsied on day 3. Hum Reprod 2009; 24: 2642-2648.
21. Van Landuyt L, Verpoest W, Verheyen G et al. Closed blastocyst vitrification of biopsied embryos: Evaluation of 100 consecutive warming cycles. Hum Reprod 2011; 26: 316-322.
22. Staton AD, Kurian AW, Cobb K et al. Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. Fam Cancer 2008; 7: 179-186.
23. Menon U, Harper J, Sharma A et al. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Hum Reprod 2007; 22: 1573-1577.
24. Quinn G, Vadaparampil S, Wilson C et al. Attitudes of high-risk women toward preimplantation genetic diagnosis. Fertil Steril 2009; 91: 2361-2368.
25. Julian-Reynier C, Fabre R, Coupier I et al. BRCA1/2 carriers: Their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis. Genet Med 2012; 14: 527-534.
26. Rodriguez-Wallberg KA, Oktay K. Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer. The Oncologist2012; 17: 1409-1417.
27. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: A measure of subjective stress. Psychosom Med 1979; 41: 209-218.
28. Woolson R, Clarke W. Statistical Methods for the Analysis of Biomedical Data. 2nd ed. New York, NY: John Wiley & Sons, 2000.
29. Hosmer D, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons, 2000.
30. Croyle RT, Smith KR, Botkin JR et al. Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol 1997; 16: 63-72.
31. van Roosmalen MS, Stalmeier PF, Verhoef LC et al. Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. Am J Med Genet A 2004; 124A: 346-355.
32. HamiltonJG, Lobel M, Moyer A. Emotional distress following genetic testing for hereditary breast and ovarian cancer: A meta-analytic review. Health Psychol 2009; 28: 510-518.
33. van Oostrom I, Meijers-Heijboer H, Lodder LN et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study. J Clin Oncol 2003; 21: 3867-3874.
34. Beran TM, Stanton AL, Kwan L et al. The trajectory of psychological impact in BRCA1/2 genetic testing: Does time heal? Ann Behav Med 2008; 36: 107-116.
35. Burgess C, Cornelius V, Love S et al. Depression and anxiety in women with early breast cancer: Five year observational cohort study. BMJ 2005; 330: 702.
36. Spencer SM, Lehman JM, Wynings C et al. Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of early-stage patients. HealthPsychol 1999; 18: 159-168.
37. Fortuny D, Balmaña J, Graña B et al. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort. Hum Reprod 2009; 24: 1000-1006.
38. Ormondroyd E, Donnelly L, Moynihan C et al. Attitudes to reproductive genetic testing in women who had a positive BRCA test beforehaving children: A qualitativeanalysis. Eur J HumGenet 2012; 20: 4-10.
39. Cameron C, Williamson R. Is there an ethical difference between preimplantation genetic diagnosis and abortion? J Med Ethics 2003; 29: 90-92.
40. Knoppers BM, Bordet S, Isasi RM. Preimplantation genetic diagnosis: An overview of socio-ethical and legal considerations. Annu Rev Genomics Hum Genet 2006; 7: 201-221.
41. Vergeer MM, van Balen F, Ketting E. Preimplantation genetic diagnosis as an alternative to amniocentesis and chorionic villus sampling: Psychosocial and ethical aspects. Patient Educ Couns 1998; 35: 5-13.
42. Wang CW, Hui EC. Ethical, legal and social implications of prenatal and preimplantation genetic testing for cancer susceptibility. Reprod Biomed Online 2009; 19(Suppl 2): 23-33.
43. Hurley K, Rubin LR, Werner-Lin A et al. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: A qualitative study of patient preferences. Cancer 2012; 118: 6270-6277.